Salvage antiretroviral therapy in HIV infection. - Wikidata - awgldk - TriplyDB

Salvage antiretroviral therapy in HIV infection.

Salvage antiretroviral therapy in HIV infection.

http://www.wikidata.org/entity/Q34519205

about

Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation Meta-Analysis of Interventions for Reducing Number of Sexual Partners and Drug and Alcohol Abuse among People Living with HIV/AIDS.Developments in virus-like particle-based vaccines for HIV.Two cases of multidrug-resistant human immunodeficiency virus infection treated with atazanavir and lopinavir/ritonavir combination therapy Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy.Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.

P2860

Q27650863-CA6E3023-D5A5-445F-92B6-E9C7BA8B6604 Q33788701-CD6C2EC4-5FCC-4381-86FA-0C1D18990011 Q37284445-FB1F8A1A-5336-4990-8206-76A5E269F056 Q38081965-C66AF049-E23E-43E0-BFF3-61CF6F3F4FC9 Q42085839-121188E5-4D26-4DBB-91A5-FB3EBB3E5DB1 Q44177588-E8164E46-A464-4E62-8A1D-22B7939417FD Q45470946-8F2A50F3-B96F-4EFF-B86D-C9928EE371C3

P2860

Salvage antiretroviral therapy in HIV infection.

http://www.wikidata.org/entity/Q34519205

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Salvage antiretroviral therapy in HIV infection.

@ast

Salvage antiretroviral therapy in HIV infection.

@en

Salvage antiretroviral therapy in HIV infection.

@nl

type

label

Salvage antiretroviral therapy in HIV infection.

@ast

Salvage antiretroviral therapy in HIV infection.

@en

Salvage antiretroviral therapy in HIV infection.

@nl

prefLabel

Salvage antiretroviral therapy in HIV infection.

@ast

Salvage antiretroviral therapy in HIV infection.

@en

Salvage antiretroviral therapy in HIV infection.

@nl

P1433

Q34519205-545401EC-790A-4E25-A1CF-0814A18C6AA5

P1476

Q34519205-E16BF445-75A1-45CD-ADAD-40D5F60E638A

P2093

Q34519205-B53A2751-2379-4F85-B66B-0CD50CD84DEC

Q34519205-E630509A-5D09-4EB9-9197-E753791CFB0F

P2860

Q34519205-07B5DE5B-125F-488A-ADB0-AD8D431C1F44

Q34519205-0CCE74A5-A8D5-499C-9BB7-9A8D679AC6EC

Q34519205-2354CF6A-F25A-4ABA-ABE5-79D8437D8A76

Q34519205-2DDAE4DA-AE42-4D03-8C5B-0919EFBE8E65

Q34519205-30545218-6F76-46D2-ADA3-698DDDE030D7

Q34519205-3524ECA8-E52C-4C87-8948-3003B3CB40D3

Q34519205-37641199-665F-4C28-8258-03EDBCA31EB8

Q34519205-45CDF7E2-8604-4627-8E2F-7EE14B95C75D

Q34519205-58F34C9D-AAED-4BA2-B5E3-AE21C74D5966

Q34519205-61933AA2-DB3C-4369-AD2C-0B6D49B08E2E

P304

Q34519205-BCF09A88-7696-458D-89A5-3F90678BFC78

P31

Q34519205-6E6E2547-5388-4819-9655-A772130B9230

P356

Q34519205-AF047D83-2FDF-4820-9813-A46E75141321

P407

Q34519205-1528D9B3-1727-4941-994F-AAC9FE3E89A1

P433

Q34519205-160D9AB4-7414-4AB1-951A-EF259FC126DD

P478

Q34519205-2F0CDEA6-98AC-4889-9C38-346FDFB2EFFB

P577

Q34519205-5378004C-ABA7-4CA6-B78A-05EEB30422E2

P698

Q34519205-576228B9-6FC2-45AE-9B24-F889C834B4BA

P921

Q34519205-1D9FDDC7-3961-4BFA-AD5B-80099F7155A2

P356

14656566.3.2.81

P1433

Expert Opinion on Pharmacotherapy

P1476

Salvage antiretroviral therapy in HIV infection.

@en

P2093

Mona R Loutfy

http://www.w3.org/2001/XMLSchema#string

Sharon L Walmsley

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens.

Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy

Amprenavir: a review of its clinical potential in patients with HIV infection.

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy.

Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations.

Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.

Strategies for long-term success in the treatment of HIV infection.

Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapy.

Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression.

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.3.2.81

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11829722

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug